key: cord-0978474-qb3ld0p4
authors: Chan, H. T. Henry; Moesser, Marc A.; Walters, Rebecca K.; Malla, Tika R.; Twidale, Rebecca M.; John, Tobias; Deeks, Helen M.; Johnston-Wood, Tristan; Mikhailov, Victor; Sessions, Richard B.; Dawson, William; Salah, Eidarus; Lukacik, Petra; Strain-Damerell, Claire; Owen, C. David; Nakajima, Takahito; Świderek, Katarzyna; Lodola, Alessio; Moliner, Vicent; Glowacki, David R.; Walsh, Martin A.; Schofield, Christopher J.; Genovese, Luigi; Shoemark, Deborah K.; Mulholland, Adrian J.; Duarte, Fernanda; Morris, Garrett M.
title: Discovery of SARS-CoV-2 Mpro Peptide Inhibitors from Modelling Substrate and Ligand Binding
date: 2021-06-19
journal: bioRxiv
DOI: 10.1101/2021.06.18.446355
sha: d9bd3d9a290797de43c9ba63207c6b5f8504c7db
doc_id: 978474
cord_uid: qb3ld0p4

The main protease (Mpro) of SARS-CoV-2 is central to its viral lifecycle and is a promising drug target, but little is known concerning structural aspects of how it binds to its 11 natural cleavage sites. We used biophysical and crystallographic data and an array of classical molecular mechanics and quantum mechanical techniques, including automated docking, molecular dynamics (MD) simulations, linear-scaling DFT, QM/MM, and interactive MD in virtual reality, to investigate the molecular features underlying recognition of the natural Mpro substrates. Analyses of the subsite interactions of modelled 11-residue cleavage site peptides, ligands from high-throughput crystallography, and designed covalently binding inhibitors were performed. Modelling studies reveal remarkable conservation of hydrogen bonding patterns of the natural Mpro substrates, particularly on the N-terminal side of the scissile bond. They highlight the critical role of interactions beyond the immediate active site in recognition and catalysis, in particular at the P2/S2 sites. The binding modes of the natural substrates, together with extensive interaction analyses of inhibitor and fragment binding to Mpro, reveal new opportunities for inhibition. Building on our initial Mpro-substrate models, computational mutagenesis scanning was employed to design peptides with improved affinity and which inhibit Mpro competitively. The combined results provide new insight useful for the development of Mpro inhibitors.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent of coronavirus disease that caused the World Health Organization to declare a global pandemic in March 2020. At the time of writing, >177 million cases of COVID-19 have been reported with >3.8 million deaths. 1 A key step in maturation of SARS-CoV-2, a single-stranded positive-sense RNA virus, is the hydrolysis of its polyproteins pp1a and pp1ab. The majority of these cleavage events-at 11 sites-are performed by the SARS-CoV-2 main protease (M pro ; also known as the 3 chymotrypsin-like or 3CL proteinase, 3C-like protease, 3CL pro ; or non-structural protein 5, Nsp5).

M pro is a homodimeric nucleophilic cysteine protease, with each protomer consisting of three domains and having a cysteine-histidine catalytic dyad (Cys-145/His-41) located near its dimeric interface. 2 SARS-CoV-2 M pro displays 96% sequence identity with SARS-CoV M pro from a closely related coronavirus, which causes SARS. 3 Dimerisation of M pro is proposed to be a prerequisite for catalysis; the N-terminal "N-finger" of one protomer contributes part of the active site of the other. 4 Indeed, the monomeric form of SARS-CoV M pro is reported to be inactive. 5 Evidence from non-denaturing mass spectrometry (MS) based assays indicates that M pro monomers are not only inactive (at least with tested substrates) but also do not bind 11-mer substrate fragments with high affinity. Gly/Ala/Ser/Asn], where "Small" denotes a small residue (Ala, Val, Pro or Thr), "X" denotes any residue, and "↓" indicates the scissile amide (Figure 1) . 7, 8 These positions in the substrates are referred to as P4-P1ʹ, and are recognised by the corresponding subsites S4-S1ʹ on M pro . In part because these sequences are not known to be recognised by a human protease, M pro is an attractive drug target. 4 Although no clinically approved M pro drugs are available, several small molecule inhibitors and peptidomimetics have been designed to inhibit SARS-CoV M pro and more recently SARS-CoV-2 M pro . 9,10 Indeed, a covalently-reacting M pro inhibitor from Pfizer has recently entered clinical trials. 11, 12 Multiple crystallographic and computational modelling studies concerning the M pro mechanism 13-16 and inhibition are available. [17] [18] [19] [20] [21] [22] (For a list of modelling studies on M pro and related coronaviruses, see the CORD-19 database 23 ). It is proposed that during M pro catalysis, His-41 deprotonates the Cys-145 thiol, which then reacts with the carbonyl of the scissile amide to give an acyl-enzyme intermediate stabilised by a hydrogen bond network that includes the scissile amide carbonyl in an 'oxyanion hole'. The C-terminal part of the product likely leaves the active site at this stage. The acyl-enzyme intermediate is subsequently hydrolysed with loss of the N-terminal product regenerating active M pro . Computational and mechanistic studies on SARS-CoV M pro 24-27 and SARS-CoV-2 M pro [28] [29] [30] suggest that His-41 and Cys-145 are most likely neutral in the active site and that the protonation states of other histidines nearby (e.g. His-163, 164, and 172) affect the structure of the catalytic machinery -although it has been suggested that the protonation state of the catalytic dyad may change in the presence of an inhibitor or substrate in SARS-CoV M pro . 31 However, a different picture has been obtained from neutron crystallographic analysis of M pro in the absence of a substrate or inhibitor, which indicates that the ion pair form of the dyad is favoured at pH 6.6. 32 While neutron crystallography, in principle, enables the direct determination of hydrogen atom positions, questions remain about how pH and the presence of active sitebound ligands influence the precise and likely dynamic protonation state of the dyad.

Key questions remain regarding M pro catalysis, including to what extent the active site protonation state, solvent accessibility, and substrate sequence influence activity. The lack of this knowledge makes it difficult to carry out effective computational studies on M pro catalysis and inhibition.

With the aim of helping to combat COVID-19, in April 2020 we embarked on a collaborative effort, involving weekly virtual meetings, to investigate the relationship between M pro substrate selectivity and activity. We employed an array of classical molecular mechanics (MM) and quantum mechanical (QM) techniques, including non-covalent and covalent automated docking, molecular dynamics (MD) simulations, density functional theory (DFT) and combined quantum mechanics/molecular mechanics (QM/MM) modelling and interactive MD in virtual reality (iMD-VR). The results provide consensus atomic-level insights into the interactions of M pro with 11-residue peptides derived from the 11 natural cleavage sites (named "s01" to "s11", in order of occurrence in the polyprotein, Figure 1a ). The identification of key interactions between M pro and its substrates, together with analysis of fragment/inhibitor structures, 33 led to design of peptides proposed to bind more tightly than the natural substrates, several of which inhibit M pro . The results are freely available via GitHub (https://github.com/gmm/SARS-CoV-2-Modelling).

It is proposed that M pro has a neutral Cys-His catalytic dyad embedded in a chymotrypsin-like fold. 34 To investigate the protonation state of the dyad following substrate binding, we studied proton transfer (PT) in the dyad with s01-bound (Figure 1a ) M pro using QM/MM umbrella sampling simulations at the DFTB3/MM and ωB97X-D/6-31G(d)/MM levels of theory. A 2.5 Å resolution structure of the H41A inactivated mutant of SARS-CoV M pro complexed with the peptide TSAVLQ↓SGFRK (PDB entry 2q6g) 35 was used to model SARS-CoV-2 M pro bound to the same peptide, s01 (Figure 1a) . His-41 was treated as N -protonated in the neutral state of the dyad, as reported by Pavlova et al. to be preferred for both apo and N3 inhibitor-bound M pro based on MD studies. 28 Cys-145 was treated as neutral, with its Sγ protonated. We investigated the effect of varying the protonation state of the dyadneighbouring residue His-163, which interacts with Tyr-161, Phe-140 and the sidechain of the substrate P1 Gln. Three His-163 protonation states were considered: (i) N -protonated neutral, or "HID"; (ii) Nprotonated neutral, or "HIE"; and (iii) both N and N -protonated and positively charged, or "HIP", using AMBER forcefield naming. 38 Both the forwards and backwards PT processes were simulated. DFTB3/MM free energy profiles showed significant hysteresis, with the neutral (N) dyad preferred in the forward direction (from neutral to zwitterionic state), and the zwitterionic state being preferred in the backward direction ( Figure S2.1) . This hysteresis likely arises from different conformations adopted by the charged Cys-145 thiolate in the zwitterionic (or ion pair, IP) state, and interactions between the thiolate and surrounding residues (Figure 2a, b) , in a) The 11 SARS-CoV-2 M pro cleavage sites, and the corresponding 11-residue fragment peptides, s01-s11, with positively/negatively charged residues in blue/red, respectively; histidine is in purple; residues with polar sidechains are in green; and cysteine is in yellow. b) Comparison between the 11 substrate sequences (generated by WebLogo) 36 highlighting the conserved Gln at P1 and the Leu predominant at P2. c) View of an energy minimised model, built using apo M pro (PDB: 6yb7, light grey surface) 37 , of M pro complexed with s05 (dark grey sticks); subsites S4-S4ʹ are labelled. The oxyanion hole formed by the M pro backbone NHs of Gly-143, Ser-144 and Cys-145 is in cyan. d) The reaction catalysed by M pro exemplified by s01. Substrate residues important in recognition (see main text) are highlighted. particular His-163. For all three His-163 protonation states, the forward trajectories (N to IP) showed the anionic Cys-145 to be stabilised solely by interaction with positively charged His-41 (Figures 2a and S2.2A-C) . In this arrangement, the thiolate is rotated away from the scissile carbonyl during PT resulting in a poor orientation for nucleophilic attack. This suggests that such a zwitterionic state is transient, with a concerted proton transfer and simultaneous nucleophilic attack of the thiolate onto the scissile amide carbon being more likely than a stepwise mechanism. 13 By contrast, the backwards PT trajectories (from IP to N) showed stabilisation of the Cys-145 thiolate in addition to that provided by His-41. In the case of HID-163 and HIP-163, the thiolate was stabilised by interactions with the His-163 N proton and the P1 Gln backbone N-H ( Figure S2.2E, F) . For HIE-163, additional thiolate stabilisation came from interactions with the backbone N-H and the hydroxyl of the P1ʹ Ser, and an additional water that diffused into the active site (Figures 2b and S2.2D) . Such hysteresis effects are common in simulations of proton/charge transfer, 39 and reflect the fact that the simulation is effectively biased towards the starting structure, or possibly limited exploration of distinct free energy basins.

The zwitterionic state with HID-163 was less stable with respect to the neutral state than the zwitterionic states with HIE-163 and HIP-163 ( Figure S2.1C) . This was due to a His-163 sidechain rearrangement in the backwards PT trajectory that results in breaking the N -H hydrogen bond with Tyr-161 and its π-π stacking interaction with Phe-140, suggesting that a N -protonated His-163 is unlikely. Double protonation of His-163 results in a loss of both interactions in the forwards and backwards PT trajectories. Despite both HIP-163 and HIE-163 giving similar PT free energy profiles, the loss of these interactions suggests HIP-163 is unfavourable for productive catalysis. These QM/MM results therefore suggest that an N -protonated neutral His-163 is most likely. Along with conserving interactions with Tyr-161 and Phe-140, an N -protonated His-163 also formed a hydrogen bond with the P1 Gln side chain (Figures 2a, b) , an interaction not observed in PT trajectories with HID-163 and HIP-163.

It is known that DFTB3 overestimates the proton affinity of methylimidazole (similar to a histidine side chain) by 30.1 kJ mol -1 . 40 Therefore, the DFTB3/MM method will over-stabilise the zwitterionic state relative to the neutral state. To account for this error, the backwards PT reaction with a N -protonated His-163 was modelled at the ωB97X-D/6-31G(d)/MM level of theory. This showed the zwitterionic state was 24.3 kJ mol -1 above the neutral state, an increase of 26.4 kJ mol -1 compared to DFTB3/MM (Figure S2.3) . Applying the free energy difference between ωB97X-D/6-31G(d) and DFTB3 at each reaction coordinate value as a correction to the combined QM/MM free energy profile in the case of HIE-163, the neutral catalytic dyad is preferred, with the ion pair being 28.5 kJ mol -1 higher in energy than the neutral state (Figure 2c ).

With the neutral form of the dyad and an N -protonated neutral His-163 established, we used the highest resolution contemporary structure of M pro available (PDB entry 6yb7, 1.25 Å resolution), 37 for simulations of M pro in complex with its 11 peptide substrates. The protonation state assignments of other histidines are given in Table  S2 .1. Our assignments agree with those of Pavlova et al. for the N3 inhibitor-bound complex, 28 and the fluorescent tag-containing polypeptide-enzyme complex reported by Swiderek and Moliner. 13 His-41 and His-164 are of particular interest. Analysis of several M pro structures (both apo and inhibitor-bound) indicates a conserved crystallographically observed water located between His-41, His-164 and Asp-187 ( Figure S2.4) ; 2, 4, 34, 37 this water (HOH-644 in PDB 6yb7) has been suggested to play a role in SARS-CoV M pro catalysis. 27 It has been noted that in PDB entry 6yb7, His-41 is in a distinct conformation compared to other M pro structures (PDB entries 6wqf, 6y2g, and 7bqy). 28 To facilitate equilibration of our simulations into a productive conformation, a rotation was applied to the imidazole of His-41 (N -protonated). Our preliminary MM MD simulations suggest that this rotamer, along with protonation of His-164 at N and retention of HOH-644, results in lower and less fluctuating root mean square positional deviation (RMSD) values for the His-41 and His-164 sidechains (Figure S2 .5).

To identify the key interactions with its substrates and to assess their relative binding affinities, we constructed models of SARS-CoV-2 M pro complexed with its 11 cleavage site-derived substrates as 11-amino acid peptides, from P6 to P5ʹ, by comparative modelling using the H41A mutant of SARS-CoV M pro bound to an N-terminal substrate 35 and the SARS-CoV-2 sequence from GenBank entry MN908947.3 41 (see Section S1.2 in Methods and Figures 1a and S2.6). We refer to these peptides as 'substrates' as their hydrolytic sites are all cleaved by M pro (vide infra). The substrates were modelled in crystallographic chain A of the M pro dimer with a neutral dyad; unless otherwise stated, all M pro residue numbers and names in the following discussions refer to chain A. Initial models were subjected to three independent MD simulations each of 200 ns.

Three of the 11 cleavage site-derived peptides (s01, s02, and s05) were also modelled using interactive MD using virtual reality (iMD-VR), as an alternative to comparative modelling and traditional MD. iMD-VR provides an immersive 3D environment for users to interact with physically rigorous MD simulations. Since the simulation responds in real-time to manipulation, iMD-VR is a useful tool for guiding generation of docked structures based on chemical knowledge; e.g. if a user tries to bring two negatively charged groups together, it will endeavour to minimise the energy of the system by moving them apart. 42 The three substrates were chosen because s01 and s02 have the highest relative efficiencies (of SARS-CoV M pro ) of all substrates; while s05 has the second-lowest catalytic efficiency but the same P2 and P1 residues as s01. 43 We hypothesised that an iMD-VR user may perceive a difference when docking these substrates, and that this perception might relate to catalytic efficiency. Indeed, the iMD-VR user found both s01 and s05 were easier to dock than s02, as s02 required manipulation of residues after initial docking to eliminate clashes between M pro and the substrate. Three 200 ns replicates of implicit solvent MD simulation were performed on each docked structure of s01, s02, and s05. It should be noted that iMD-VR has successfully produced accurate docked structures of various drug-viral enzyme complexes, including oligopeptide-and inhibitor-M pro complexes. 44, 45 Throughout both the explicit-solvent MD of all 11 substrates and the implicit-solvent MD simulations of iMD-VR structures of s01, s02, and s05, all substrates remained tightly bound in the active site (see backbone RMSD, and root mean square fluctuation or RMSF analyses in Figures S2.7-10) . Backbone stability is maintained especially in the central region of the substrates, with only the N-and C-terminal residues showing substantial flexibility. Local sidechain fluctuations are present, notably at the P3 residue which occupies the solventfacing S3 subsite (Figure 1c ; RMSF plot in Figure S2 .8). Another clear trend is that the C-terminal Pʹ-side residues consistently fluctuate more than the N-terminal P-side residues, likely in part as a result of fewer protein-substrate hydrogen bonds on the Pʹ side (vide infra).

Crystallographic studies on SARS-CoV M pro reveal the importance of hydrogen bonds in binding of substrate s01, 35 which has the same cleavage site sequence in SARS-CoV-2 (Figure 1a) . To investigate whether this is the case for SARS-CoV-2 M pro in complex with its substrates, we analysed the prevalence of hydrogen bond (HB) interactions at each subsite for all 11 substrates, in both explicitsolvent MD and implicit-solvent MD simulations of iMD-VR docked structures. Twelve key HBs were identified (Figure 3 ) and monitored, with distance and angle distributions shown in Figure S2 .11.

In both the explicit-solvent MD and iMD-VR simulations, all 11 substrates are primarily held in place by stable backbone-backbone HBs (numbered 2, 3, 10 and 11 in Figure 3) , involving M pro Glu-166 at S3 (2, 3) and Thr-26 at S2ʹ (10, 11) . Both residues consistently form significant contact interactions and energy contributions (vide infra). The backbone HBs further away from the cleavage site, i.e. HBs 1 and 12, show greater variation in explicit water, and HB 1 is completely absent in s07 and s11 where P4 is Pro. By contrast, both of them are well conserved in the iMD-VR-generated structures. In both approaches, HB 4, which involves the flexible Gln-189 side chain, is formed only intermittently. -substrate hydrogen bonds (HBs), using substrate s01 as an example. b) An annotated heat-map displaying the frequency of each HB observed, with blue indicating highest frequency. Frames were extracted every ns from 600 ns of cumulative explicit-solvent MD conducted per system. c) Close-up of the MD-generated binding mode of SARS-CoV-2 M pro -substrate s01 with subsites S1, S2, S1ʹ and S2ʹ labelled. Two different angles of the S1 subsite are shown, emphasizing the deep S1 pocket that accommodates the P1 Gln sidechain. Subsite surface colour corresponds to the hydrophilicity score, with hydrophobic subsites shown in yellow, hydrophilic subsites in dark blue, and neutral subsites in turquoise. d) Hydrophilicity map for the 11 substrates calculated as the sum of hydrophilic interactions subtracted from the sum of hydrophobic interactions. Interactions were obtained through analysis of substrate MD poses by Arpeggio 46 (see Methods Section S1.5).

The P1 Gln is conserved in all 11 M pro cleavage sites (Figure 1a, b) : while individual HBs formed in the S1 site (HBs 5-9) are observed less frequently than HBs 2, 3, 10 and 11, they outnumber other sites. In explicit-solvent MD simulations, HBs 6 and 8 predominate (Figure  3b ). In the iMD-VR simulations of s01, s02 and s05, HBs 5, 6, and 7 show variation, while HBs 8 and 9 are well conserved in all three substrates. The consistency in HB 8 formation suggests that this interaction could play a fundamental role in catalysis.

The Cys-145 backbone amide forms part of the oxyanion hole, which stabilises the tetrahedral intermediate formed upon nucleophilic attack of Cys-145 Sγ on the scissile amide carbonyl. M pro 's exquisite specificity for Gln at P1 is likely based on the formation of HB 6 with His-163, and to a lesser extent HB 7, along with the narrowness of the S1 pocket accommodating the Gln sidechain in an extended conformation.

To obtain more detailed information on the nature of the interactions in each subsite, we generated a hydrophilicity map (Figure 3d ). As expected, the S1 subsite has a substantial hydrophilic character consistent throughout all substrates. Although only two highly conserved contact residues were identified between the S2 subsite (Met-49 and Met-165) and all 11 substrates, the character of S2 is nonetheless consistently hydrophobic. In accord with the HB analysis (Figure 3b) , the conservation of the subsites decreases with increasing distance from the cleavage site. Although subsites S3 and S2ʹ show a slight bias towards hydrophilic interactions, none of the other subsites show a consistent pattern across the different substrates.

Beyond HBs, several other interaction types are conserved across the substrates; these were identified by running Arpeggio 46 on snapshots extracted from the explicit-solvent MD simulations. As seen in Figure  4 , 6 out of the 8 most common P1 interactions are conserved across most substrates. This includes the previously described HB pattern between the P1 backbone oxygen and the backbone NHs of Cys-145 (HB 8) and Gly-143 (HB 9) that constitute the oxyanion hole, as well as HB 6 (with His-163) and HB 7 (with Phe-140) that stabilise the P1 Gln sidechain. In addition, interactions with residues Ser-144, His-163, His-164, Glu-166 and, to a lesser extent, Phe-140 were highly conserved at subsite S1. None of the other subsites show this level of consistency in residue-level contacts, although some individual interactions such as hydrophobic interactions at Met-49 and Met-165 were always present in subsite S2. Furthermore, important stabilising backbone HBs (HBs 2-3 between Glu-166 and P3; and HBs 10-11 between Thr-26 and P2ʹ) were conserved with all substrates. Finally, this residue-level contact analysis reveals that the Pʹ contacts are in general preserved less often than the P side (Figure 4) . The same trend was found when docking s01, s02, and s05 using iMD-VR, where Pʹ-side residues tended to be more flexible than P-side residues. 

We analysed van der Waals and electrostatic contributions to protein-substrate interactions by employing the molecular mechanics-generalised Born surface area (MM-GBSA) method. 47, 48 This approach has been used for identifying protein hotspot residues that contribute significantly to ligand binding, with a crude estimation of the effects of solvation. 49, 50 The ten M pro residues contributing most to the binding energy were identified for each of the 11 substrate complexes. These hotspot residues were largely conserved across substrates ( Figure S2 .12), with the most frequently-identified residues (and their occurrences across the 11 systems) being: Glu-166 (11), Thr-26 (11), Met-165 (11), His-41 (11), His-163 (10), Cys-145 (10), Pro-168 (9), Thr-25 (8), Gln-189 (8), Thr-24 (6), Thr-190 (6) . These residues are all within proximity to the complexed substrate ( Figure 5 ) and were also identified by Arpeggio as conserved contacts ( Figure 4 ).

As anticipated, residues that form the most stable HBs (HBs 2, 3, 10, 11), namely Glu-166 and Thr-26, display large favourable contributions ( Figure 5 ). Further insight could be gained from decomposition into their respective backbone and sidechain components. Interestingly, while the contributions from their backbones are comparable, as expected from their similar modes of HB formation, Glu-166 has a larger total contribution due to its sidechain, which is adjacent to the conserved P1 Gln sidechain. Other HB-forming residues (backbones of Cys-145, Thr-190, and Thr-24; and sidechains of His-163 and Gln-189) are also identified as hotspots. For the remaining key residues, contributions to binding are dominated by van der Waals interactions ( Figure S2 .13), as exemplified by Met-165 and His-41, both of which engage in nonpolar contacts with the hydrophobic P2 residue. Optimising interactions with these hotspot residues could help guide the design of optimal M pro inhibitors.

Similar per-residue decomposition of binding energy contributions was performed at each substrate position. Given the variation in sequences, the contribution from each position varies across substrates ( Figure S2.14) . Nevertheless, binding contributions from the P4, P3, P1 and P2ʹ backbones are observed with all substrates, in agreement with the observation of HBs between these residues and M pro residues (Figure 3 ). Contributions from the P2 sidechain are significant (Figure S2.15 ).

The S2 site appears to tolerate Phe (s02) well, in addition to the more common Leu that is found in nine of the eleven substrates, while Val (s03) is less favourable. The possibility of filling the S2 pocket with a larger, aromatic moiety is of interest in designing inhibitors.

We performed linear-scaling DFT calculations on the entire solvated M pro -substrate complexes by applying the BigDFT code. 51 This formalism enables the automatic decomposition of large molecular systems into coarse-grained subsets of atoms, or 'fragments', in an unbiased manner. 52 With such a reduced-complexity description, quantities like inter-fragment bond analysis and interaction strengths can be easily quantified.

Initial comparison between the interaction energies computed from BigDFT and those obtained using classical force fields shows good correlation ( Figure S2.16) , providing further support for the MD results. It also suggests that charge-polarisation, which DFT partially captures but which is absent in force-field based MD, does not play a major role in the studied substrate-enzyme interactions with electrostatic interactions being more important (Figure S2 .17).

Using representative snapshots extracted from explicitly solvated MD trajectories of M pro complexed with s01, s02, and s05 as inputs for BigDFT calculations, we generated a QM interaction (contact) map to identify interactions between substrates and M pro . The strength of the interaction was quantified by the contact interaction energy, Econt, which is defined as the partial trace of the system's Hamiltonian between fragments (Figure 6a ). By computing this quantity between dimeric M pro and s01, with either one or both sites occupied, we were able to evaluate cooperativity effects on binding.

The obtained values are within error (Econt = -736 ± 119 and -699 ± 95.0 kJ mol -1 for one or two substrates bound to the dimer, respectively), suggesting that no significant cooperativity operates between the two active sites in the M pro dimer (at least with investigated substrates). Moreover, no preference for binding in a particular site was observed.

This analysis also recapitulated the key roles of Glu-166 and Thr-26, with interactions observed in all three peptides s01, s02, and s05. This is consistent with the HB analysis described earlier (Figure 3) . It shows that Gln-189 consistently forms an HB with P2 (HB 4) in s01 and s05, but rarely with s02. The P2 residue in s01 and s05 is Leu, while in s02, P2 is Phe, the bulk of which may weaken the HB. Finally, a strong interaction between Ser-46 and the P3ʹ-Glu sidechain is observed for s05 (P3ʹ=Glu), but not s01 or s02 (P3ʹ=Phe and Val, respectively), suggesting the P3ʹ-Glu carboxylate is important in forming a strong HB with Ser-46.

From this analysis, a graph-like view of substrate-enzyme interactions can be obtained, enabling identification of the most relevant (MD-averaged) interaction networks (Figure 6b ). Note the interactions are predominantly on the non-prime side of all three substrates. Figure 3 and 3D representation of key residues for s02 in Figure 5 . b) Interaction networks where the colour of the nodes refers to the interaction strength, ranging from dark blue for the strongest through green to yellow for the weakest interactions. Square nodes belong to substrates, while circular nodes belong to M pro . The width and colour of the edges indicate the fragment bond order between residues, which is a unitless measure associated with bond strength (analogous to an atomic bond order), ranging from black for the strongest to orange for the weakest. 52 Interaction energies and maps were computed using ensemble-averaged results of MD snapshots using the BigDFT code.

A conserved contact is present in the three substrates between Cys-145 and both P1 and P1ʹ residues. Interactions between His-41 and P2/P1ʹ are observed for s01 and s05, and between Glu-166 and P1/P3 (and, to some extent, to P4) for all three substrates. This analysis singles out the character of s02, which is dominated by the bulky character of its P2 Phe. Substitutions in this region may have a substantial effect on the interaction network close to the catalytic site. While the P side exhibits an interconnected character, the network on the Pʹ side has a more linear character, once again indicating that hot-spot residues responsible for binding are present on the P side. The relevant interactors on the P side range from P1 to P4, as the interaction graphs show relatively intricate patterns in this region of the substrates. Distributions around the average values are shown in Figure S2 .18.

The following trends emerge from our studies on models of M pro in complex with its 11 substrates: (i) Binding stability is partly conferred by a series of HBs ranging from the P4 to P4ʹ positions, in particular those between the backbones of M pro Glu-166 and Thr-26 and substrate positions P3 and P2ʹ respectively, as well as HBs involving the conserved P1 Gln sidechain; (ii) substrate residues N-terminal of the cleavage site (P side) form a larger number of, and more consistent, contact interactions with M pro compared to the Pʹ side, with interactions contributed by M pro residues Met-49, Gly-143, Ser-144, Cys-145, His-163, His-164, Met-165 and Glu-166 being the most conserved. We conclude that the S1 and S2 pockets are prime targets for active site substrate-competing inhibitor design due to their welldefined hydrophilic character, large energy contribution to substrate binding and vital conserved hydrogen bonds in S1 for substrate recognition.

While others have compared the dynamics of ligand binding sites across SARS-CoV-2, SARS-CoV and MERS-CoV M pro , 53 we investigated the conformational plasticity of the SARS-CoV-2 M pro active site exhibited in 333 M pro :ligand co-crystal structures obtained from Fragalysis 54 by comparing to a reference apo structure of M pro (PDB entry 6yb7), 37 calculating per-residue heavy atom RMSD between the active site residues of the apo and protein-ligand bound structure (Figure 7) . A high degree of plasticity was observed at residues Thr-24, Thr-25, His-41, Thr-45, Ser-46, Met-49, Asn-142, Met-165, Glu-166, Arg-188, Gln-189 and Ala-191. By contrast, the S1 subsite is particularly rigid, with almost no change in residue conformations across all 333 crystal structures. This is not surprising considering that the P1 Gln is conserved in all 11 substrates. In all cases, Gln recognition is mainly driven by proteinsubstrate interactions with residues Gly-143, Ser-144, Cys-145 (oxyanion hole) as well as His-163 and Phe-140. On the other hand, the S2 subsite is highly flexible, especially at residues Thr-45, Ser-46 and Met-49. Although the P2 residue in all 11 substrates is conserved in terms of hydrophobicity (Leu, Phe, Val), the S2 pocket is highly flexible and can adapt to accommodate smaller functional groups such as aliphatic carbons in leucine, but also larger substituted aromatic groups found in many of the analysed co-crystal ligands. The outer regions of the active site corresponding to subsites S3-S6 and S2ʹ-S5ʹ vary in flexibility, echoing our observations from our MD simulations. Active site binding ligands in the 333 co-crystal structures are most likely to bind around S2-S1ʹ and should only affect the conformation of some of the outer subsite residues. A 3D overlay of all 333 co-crystal structures (Figure S4.4) highlights the plasticity at S2.

To rank the SARS-CoV-2 M pro preferences for hydrolysis of the 11 assigned SARS-CoV-2 cleavage sites, we monitored turnover of 11mer peptides by solid-phase extraction (SPE) coupled to mass spectrometry (MS). Interestingly, after the N-terminal autocleavage site s01, s11 was found to be the next preferred substrate for catalysis ( Figure S2.20) . Peptides s06, s02, and s10 were also hydrolysed, but less efficiently than s11. Slow turnover was observed for s07 and s09. Evidence for low turnover of s05 was obtained after prolonged incubation with M pro (9.56%) (Figure S2.21) . Under our standard conditions, no evidence for cleavage was observed for s03, s04, and s08.

We then examined turnover under non-denaturing MS conditions using ammonium acetate buffer (Figure 8a ). Peptides s01, s06, s08, s10 and s11 demonstrated evidence for fast turnover. The level of substrate ion depletion was >70% after 1-min and >90% after 6-min incubation. Peptides s02, s04 and s09 showed substrate ion depletion from 35 to 45% after 1-min incubation, >70% depletion after 6 minutes, and >90% depletion after 12 minutes; while peptides s03, s05 and s07 demonstrated slow turnover with <20% depletion after 1-min incubation and <50% turnover after 6-min incubation that also remained below 50% after 12-min incubation. In the protein region of the mass spectra, complexes between M pro dimers and the cleavage products were observed starting from 1 min of incubation for the fast-turnover substrates s01, s06, s08, s10 and s11, and also s02, s04 and s09 (Figure 8b1-4) . For the slow-turnover substrates s03, s05 and s07, M pro complexes with the intact substrates were observed after 1-min incubation. For longer incubation times, complexes between M pro and the products from these substrates emerged and increased in abundance (Figure 8b5-6) .

The rank order of the substrates depends on the MS method used, likely due to the differences in the buffers and concentrations used: i.e., non-denaturing MS used ammonium acetate buffer and an M pro concentration of 5 μM, which is higher than the 0.15 μM used in denaturing MS assays. The higher concentrations of both enzyme and substrate in the non-denaturing MS experiments explain the faster substrate turnover observed in comparison with the denaturing MS method, especially as the concentration of catalytically active M pro dimer would be higher at a higher enzyme concentration. 6, 55 Regardless of the MS method used, a clear trend is observed in the catalytic turnover of the cleavage site-derived peptides. The rank order of substrate preference under denaturing MS conditions was s01 > s11 > s06 > s02 > s10 > s07 > s09 > s05 (Figures S2.20-21) . Under non-denaturing conditions (Figure 8 ) it was: fast turnover (s01, s11, s06, s10, and s08), medium turnover (s04, s02, and s09), and slow turnover (s05, s03, and s07). Substrates s01, s11 and s06 demonstrated the most rapid turnover; while s07, s05 and s03 turnover was slow as measured by both methods. This is in broad agreement with the reversed-phase high performance liquid chromatography analysis of substrate turnover by SARS-CoV M pro , where s01 and s02 display fast turnover; s10, s11 and s06 manifest medium turnover; and the rest of the substrates s09, s08, s04, s03, s05, s07 display slow turnover. 43 Both of our MS studies on SARS-CoV-2 M pro indicate that s02 consistently displayed slower turnover than s11. Previous reports on SARS-CoV M pro have shown evidence for cooperativity between subsites during substrate binding, in particular during autocleavage of the M pro C-terminal site (s02), where the Phe at P2 induces formation of the S3ʹ subsite to accommodate the P3ʹ Phe residue. 56 SARS-CoV-2 M pro substrate s02 has Phe at P2, but not at P3ʹ (Figure 1a) . The absence of a Phe at the P3ʹ position may explain in part the reduced activity of SARS-CoV-2 M pro for s02 relative to s01, compared to the same pair in SARS-CoV M pro . 43 The observed turnover of all 11 SARS-CoV-2 cleavage-site-derived peptides by M pro is consistent with our atomistic models, where the peptides remain bound in the active site during MD simulations and where the scissile amide carbonyl remains well-positioned in the oxyanion hole (e.g., HB 8 in Figure 3 ) for reaction initiation. The stability of the M pro -peptide interactions involving the key S2 and S1 subsites as well as backbone-backbone HBs 2, 3, 10 and 11, could explain the observation in non-denaturing MS of complexes of M pro with products -as a result of slow product dissociation. Nevertheless, we envisage that the order of substrate turnover rates is likely determined by various factors, including peptide conformations, the influence of the P2 and P1ʹ residues on the catalytic dyad (as highlighted by the BigDFT analysis), entropic effects, and rates of product dissociation, all of which prompt ongoing experimental and computational investigations.

Building on insights gained from our binding studies of SARS-CoV-2 M pro and the 11 SARS-CoV-2 polypeptide substrate sequences, we designed peptides that could bind more tightly than the native substrates. We computationally quantified the contribution of each residue of these sequences to the overall binding in the M pro active site and suggested substitutes at each position that would increase affinity. We hypothesised that these peptides would: a) behave as competitive inhibitors, and b) provide counterpoints for comparison with natural substrates, shedding light on the requirements for M pro binding and, perhaps, turnover.

We used the interactive web application BAlaS to perform computational alanine-scanning mutagenesis (CAS) using BudeAlaScan 57 and the BUDE_SM algorithm. 58 Both are built on the docking algorithm BUDE, 59 which uses a semi-empirical free energy force-field to calculate binding energies. 60 To identify key interactions determining the binding of the natural substrate peptides to M pro , the 11 substrates in complex with M pro were first subjected to CAS using BAlaS. By sequentially substituting for alanine, the energetic contribution of each residue to the overall interaction energy between the singly-mutated peptide and M pro is calculated using:

where ΔGWT is the interaction energy between the peptide and M pro , and ΔGALA is the interaction energy for the peptide with a single alanine mutation at a given position. The more positive the value for each residue, the greater the contribution from the substrate residue to binding. This method was used later to evaluate potential inhibitor peptides.

Having identified residues contributing most to the binding energy of the natural M pro substrates, each of the sequences was subjected to saturation mutagenesis using the BUDE_SM algorithm. This algorithm sequentially substitutes each residue with a range of residues (D, E, F, H, I, K, L, M, N, Q, R, S, T, V, W and Y) and calculates the ΔΔG = ΔGWT -ΔGMUT for the binding interaction of each, entire, singly mutated peptide with M pro . Substitutions predicted to improve binding over wildtype sequences have a positive ΔΔG. Figure 9 shows an example of the BUDE_SM saturation mutagenesis results for all the P2 substitutions for the 11 substrate peptides (normally Leu, Phe, or Val in the 11 substrates). The most positive results suggest that Phe, Trp and Tyr favour increased predicted affinity at P2 (Figure 9b) . However, although Tyr generally increased the predicted binding affinity (ΔΔGSUM = 68.8 kJ mol -1 ), it was not considered for substitution at P2 due to its negative effect at this position in s11 (scoring -18.9, Figure 9a ). Candidate residues for each position, P6 -P5ʹ, were shortlisted similarly based on those with the best total, and the fewest unfavourable, scores (Figure 9a ).

In addition to the computed ΔΔG values for the substrates, the contribution each residue makes to promote an extended conformation was considered. All of s01-s11 adopt a largely extended conformation on binding; it was, therefore, decided that entropic penalties may be avoided if an inherently extended conformation could be favoured in the design of any potentially inhibiting peptide. Thus, the best β-forming (and therefore least αforming) residues from the first triage were selected (Figure 10a) . 61 Another important consideration was solubility. This was achieved by limiting the number of hydrophobic residues in each designed peptide and ensuring a net positive charge (with the exception of p14, where we tested a neutral peptide).

Employing the criteria described above, five new peptides, p12-p16, were designed (Figure 10b) . Comparison of the computed ΔΔG values for s01-s11 (Figure 10c ) and p12-p16 (Figure 10d ) reveals that substitutions at the P sites provide only occasional, moderate improvements to binding energy over the corresponding substrate P sites, with the notable exception of P2, which can accommodate Trp, Phe or Lys. These results are in line with the HB analysis which predicts that the sidechains of residues that are on the N-terminal side of the cleavage site (P sites) contribute more to binding than those C-terminal, at the Pʹ sites. The most striking difference between substrate and designed peptides is in this Pʹ region, where the predicted binding energy contributions for the designed peptides exceed those of the substrates; an advantage that is distributed over most of the designed Pʹ positions. The final step in design was to assess the relative binding affinities of the substrates and designed peptides. Hence the summed ΔΔGs (Figure 10e ) provide a proxy for the binding energies (BAlaS) 62 for the substrates and designed peptides with M pro . The substrate/M pro complexes are stabilised by an average of 46.5 kJ mol -1 , whereas the designed-peptide/M pro complexes are predicted to have, in some cases, double the interaction stability of the substrates, with an average of 96.0 kJ mol -1 . The full analysis is in the SI file SI_BAlaS_BUDE_SM_07-06-2021.xls.

To test the designed sequences, p12, p13, p15 and p16 were synthesised with a carboxyl-amide terminus by automated solid phase synthesis. Their M pro inhibitory activity was determined by dose-response analysis ( Table 1) using SPE MS, monitoring both substrate s01 (1191.68 Da) depletion and N-terminally cleaved product (617 Da) formation. Ebselen which reacts multiple times with M pro 63 was used as a standard (IC50 = 0.14 ± 0.04 µM) ( Figure  S3 .1f). (Figure S3.1) . Strikingly, despite the presence of Gln at P1 in all the designed peptides that were assayed, no evidence for hydrolysis was observed by SPE MS. This observation was supported by LCMS studies of the peptides incubated overnight with M pro (Figure S3.3) . We probed the inhibition mode of the designed peptides by monitoring changes in IC50 while varying the substrate concentration. Dose-response curve analysis performed with 2 µM, 10 µM, 20 µM and 40 µM TSAVLQ↓SGFRK-NH2 s01 (Km ~14.4 µM) 63 indicated a linear dependency between substrate concentration and calculated IC50 values (Figure 11a-d) . This was not observed with a control 15-mer peptide or ebselen (Figure 11e, f) . Analysis of the data using the procedure of Wei et al. 64 implies competitive inhibition (Figure S3.4 and Tables S3.1-2). By contrast, the same analysis for ebselen did not support competitive inhibition, consistent with MS studies showing it has a complex mode of inhibition. 63 Three of the synthesised peptides -p12, p13, and p15 -have a Trp at P2 (Figure 10b ) while the other, p16, has a Lys at P2. The 11 M pro substrates all have hydrophobic residues (Leu, Val or Phe) at P2 (Figure 1a) . To investigate if the nature of the hydrophobic residue at P2, or the hydrophilic nature of the Gln at P1, alters the interaction of the peptide and hence its catalysis in the active site, we synthesised p13-WP2L, s01-LP2W, and s01-QP1W. There was no evidence for cleavage of p13-WP2L or s01-QP1W. Only s01-LP2W underwent partial cleavage (12.6 ± 4.5) % after overnight incubation. These results suggest that the presence of a Trp at P2 hinders catalytically productive binding, at least with these peptides, and that other residues (including the P1ʹ and P2ʹ residues) play a role in orienting the substrates for cleavage (vide infra).

We then used non-denaturing protein MS to study enzymesubstrate/product/inhibitor complexes simultaneously with turnover. Complexes between M pro dimer and p12 and p13 were observed, together with the uncomplexed M pro dimer in the protein region of the mass spectra. No binding was observed for p15 and p16, due to relatively high noise in that m/z region. None of the designed peptides were cleaved by M pro , as recorded in the peptide region. As a control, s01 was added to the protein/inhibitor mixtures; for all the inhibitors, turnover of s01 was observed after 3-min incubation. Depletion of s01 was 95%, 91%, 70% and 78% in the presence of p12, p13, p15 and p16, respectively, with an 8-fold excess of inhibitor over M pro , versus >98% depletion for the M pro /s01 mixture without the inhibitor. In the protein region of the mass spectra, complexes between M pro dimers and the s01-cleavage products were observed in the presence of p13, but the abundance of these complexes was lower than the abundance of M pro /p13 complexes (Figure 12) . These results validate the above-described evidence that the peptide inhibitors both bind and competitively inhibit M pro .

To investigate binding of the designed peptides, models of dimeric SARS-CoV-2 M pro complexed with p12 (KYTFWQ↓YSQFY) and p13 (KYLTWQ↓NSQIN) were constructed using a high-resolution structure (PDB entry 6yb7). 37 Modelling of the peptides was carried out using conventional explicitly-solvated MD, iMD-VR, and linearscaling DFT. For iMD-VR, each simulation was repeated five times, with both the dimeric M pro and the peptide treated as fully flexible.

For each peptide, each of the five structures created by iMD-VR was minimised, equilibrated for 4 ns, and subjected to 500 ns of MD. Separately, comparative modelling was also performed: for this, sidechain substitutions were performed to convert the earlier modelled M pro -bound s02 peptide into the designed sequences ( Figure S3.5) , before conducting three independent 200 ns MD simulations for each complex in explicit solvent. Table S3 .2. See Experimental Section S1.8 for assay details. indicates sequential binding of s01-cleavage products (note: the resolution is not sufficient to distinguish between the N-and C-terminal fragments; some non-specific binding of p13 is also observed in c) and d) due to the high concentration of the peptide).

Regardless of the methods employed, p12 and p13 were observed to bind stably at the active site over the course of simulations ( Figures  S3.6-9) . Similar to the trend with the substrate complexes, the backbone-backbone HBs involving Glu-166, Thr-26, Thr-24, and the oxyanion hole-contributing Cys-145 were all formed and maintained (Figures S3.10-12) . Conversely, HBs involving the P1-Gln sidechain of p12 and p13 showed greater variability.

The favourability of the P2 Trp, as predicted by the BAlaS scores, together with the plasticity observed at the S2 site in our structural analysis, prompted us to investigate its binding. Across the simulations, the Trp sidechain was observed to adopt a variety of conformations with varying degrees of immersion in S2 (Figures 13  and S3.13-14) . In the case of the iMD-VR docked structures, the S2 pocket seemed to change relative to the crystalographically observed conformation, leaving more space in the pocket, resulting in many P2 Trp conformations. This could be due to disturbance of the S2 atoms in iMD-VR simulations, or due to innate plasticity of the S2 site (see Section 2.2). An additional iMD-VR docking simulation was performed for p12 and p13, where the focus was on not deforming the S2 pocket. The resulting docked structures of both p12 and p13 were subjected to three independent 100 ns implicit solvent MD simulations; representative P2 Trp conformations in each simulation are in Figure 13 . Analysis of the poses of the highest populated cluster from MD using Arpeggio-generated hydrophilicity maps (Figure S3.15 ) reveals that the P2 Trp can become more deeply buried within S2 than the analogous P2 residues in the natural substrates, forming more than double the number of hydrophobic contacts in the cases of p12 and p13. Some conformations involve the indole group π-π-stacking or hydrogen-bonding (via the indole N-H) with the catalytic His-41 sidechain forming an extended HB network (Figure 13) . It is likely these interactions will affect the reactivity of His-41 in deprotonating Cys-145 during the initiation step of peptide hydrolysis.

For comparison, we performed the same DFT-based interaction network analysis as for the substrates (Figure 6b ) with p13 ( Figure  14) . The interaction graphs near the cleavage site are similar to those for s05, with the P2 Trp interacting with Asp-187. The interaction with His-41, which was not visible in the case of s02 (P2=Phe), is now restored as in the P2 Leu of the other substrates. This analysis suggests that s05 and p13 exhibit the same short-range interaction network. 

To investigate the ability of the M pro subsites to recognise residues in the designed sequences, AutoDock CrankPep (ADCP) was used. 65 A trial was performed by redocking the s01 sequence into the H41A SARS-CoV M pro structure originally complexed with s01 (PDB entry 2q6g). 35 ADCP successfully positioned the peptide mostly correctly in its top solution, with the Ca positions from P5 to P1ʹ deviating by less than 1 Å (Table S3 . 4 and Figure S3 .16). Deviations increased up to 16 Å at P5ʹ as the peptide coiled up in the Pʹ positions, but this is deemed acceptable since the Sʹ subsites are less well defined, as discussed in the earlier sections.

Following the promising redocking results with ADCP, s01-s11, p12, p13, p15, and p16 were docked with an M pro structure originally complexed with the N3 inhibitor (PDB entry 7bqy; 1.70 Å resolution). 2 In the case of the substrates, docked structures having the P4 and P2 residues correctly positioned in their corresponding S4 and S2 pockets were consistently found in at least one of the top 10 solutions (Table S3 .5). From P1 onwards greater variation was observed, with some peptide backbones falling through the S1 pocket rather than adopting an extended conformation, likely due to the less well-defined Sʹ subsites (Figure S3.17) . For the designed peptides, by contrast, docking appeared less successful (except p16), with none of the top 10 solutions positioning the peptide in the manner observed in our MD simulations (Figure S3.18) . We anticipated that the existing S2 pocket in the structure, which accommodates the Leu sidechain of N3, might be too shallow, given the assumption of a rigid receptor in ADCP docking, to accommodate the larger Trp side chain. Hence, the four inhibitor peptides were also docked to the C145A M pro structure in complex with the s02 cleaved product (PDB entry 7joy; 2 Å resolution), 66 which has a deeper S2 pocket adapted to the P2 Phe sidechain in s02. Interestingly, for both p12 and p16, the top docked solution matched our design more closely (Table S3 . 6 and Figure S3.19) . Docking of p13 and p15 remained challenging, possibly due to the difficulty of recognising a larger Leu (p13) or Ile (p15) residue in the S4 pocket, which originally accommodates a Val side chain. This highlights the potential of M pro active site pockets to adapt their shapes when binding to different substrates or inhibitors.

In summary, we used in silico saturation mutagenesis to design peptide sequences that were shown in vitro to inhibit M pro competitively. Structures of p12 and p13 generated by both iMD-VR docking and comparative modelling were similar in terms of HB formation and peptide backbone RMSD and RMSF on performing MD. These studies demonstrate the ability of the S2 subsite to adapt its pocket size and interaction network via induced fit to accommodate different substrate or inhibitor P2 residues.

While these models suggested similarly stable binding modes as seen with the natural substrates, turnover of these inhibitor peptides by M pro was not detected. This may be due to the more favourable binding affinity predicted by BUDE, in terms of both the higher overall interaction energies and the increased contribution by the Pʹ residues, in comparison with the natural substrates. This may as a consequence increase the stability of the designed peptide complexes. It is also possible that the larger P2 residue interferes with the catalytic His-41 residue, given their proximity seen in MD simulations (Figure 13 ).

Having identified key interactions by which M pro recognises its substrates, we hypothesised that this information might be reflected in the extensive small-molecule inhibitor work on M pro and could, in turn, be exploited for the design of novel small-molecule inhibitors.

In particular, we explored whether ligands that adopt the same key contacts as the natural substrates could lead to better inhibitory activity. To investigate this, we utilised all 91 X-ray structures of small molecule fragments complexed with M pro obtained by highthroughput crystallographic screening at Diamond's XChem facility 67 as well as the dataset of 798 inhibitors and 245 crystal structures obtained from the COVID Moonshot project 33 and analysed them by their protein-ligand interaction patterns.

Our analysis divided fragment binding into non-active-site binders (25 fragments) and active-site binding / likely substrate competing (66 fragments) molecules (Figure S4.1) . A fingerprint bit-vector was constructed for every active-site binding fragment, with each bit denoting the presence or absence of an interaction with every M pro protein residue found to interact with either a substrate or fragment. A distance matrix was created by calculating the Tanimoto distance 68 between interaction fingerprints. Fragments were then clustered using the interaction Tanimoto similarity index. A similarity score of 1 corresponds to perfect overlap of all fragment-residue level contacts, and 0 denotes no overlap. Note that the Tanimoto index is computed between Arpeggio-derived contact fingerprints rather than ligand structure extended-connectivity fingerprints (ECFPs). For this analysis, a tighter (0.7) and broader (0.5) threshold were chosen. The former was found to be better at distinguishing distinct binding modes, while the broader threshold was more useful in grouping binders around major significant interactions (see Table S4 .1 and Figures S4.2-3 for further details). We focus on the results obtained from the broader 0.5 threshold clustering (Figure 15 ).

Surface of the x0830bound M pro structure (in white) and the top 5 most populated fragment clusters using a clustering threshold of 0.5. a) Cluster 1 fragments tend to occupy S1ʹ (green); b) clusters 2 (cyan) and 3 (yellow) tend to span S1ʹ and S2; c) clusters 4 (lilac) and 5 (salmon) tend to occupy S2 and S1. d) Close-up on the binding pose of cluster 5. Shown in green dotted lines are the two key HBs between the fragment carbonyl oxygen and the backbone nitrogen of Glu-166 (HB 3 in Figure 3 ) and between the His-163 N and the heterocyclic nitrogen of the fragment (HB 6 in Figure 3 ). e) Overlay of the P4-P1ʹ-truncated structure of peptide inhibitor p13 from an MD snapshot and cluster 5 binder x0678, on the corresponding x0678 co-crystal structure molecular surface.

All the fragments and ligands belonging to clusters 1-2 (except x0397, x0978 and x0981) are covalently bound to Cys-145. As a result, a highly-conserved binding mode is observed for the carbonylcontaining covalent warheads (e.g., chloroacetamides), where the carbonyl oxygen close to the covalent warhead binds into the oxyanion hole between residues Gly-143 and Cys-145, mimicking substrate HBs 8 and 9 identified in Section 2.2.1 (Figure 3) . Among the other clusters, cluster 5 stands out as it the only major cluster with fragments that bind deeply into the S1 pocket, having one of the main conserved contacts identified for the substrate peptides. This cluster shows a distinct binding motif primarily driven by (i) hydrogen bonding between a carbonyl oxygen on the fragment and the Glu-166 backbone NH-group, and (ii) a strong polar interaction between His-163 and the fragment. Notably, the position of the hydrogen on the imidazole sidechain of His-163 appears to depend on the HB fragment partner.

Based on the presence or absence of either a HB donor or acceptor on the fragment, the protonation state of His-163 can be inferred. This suggests that for x0107, x0434, x0540, x0678 and x0967, the His-163 -nitrogen is protonated, forming a HB to the pyridine nitrogen (x0107, x0434, x0540 and x0678) or phenol oxygen (x0967). For x1093, the -nitrogen is protonated, leaving the -nitrogen free to form a HB with the indole -NH of x1093, reversing the HB polarity compared to the other fragments in the cluster. Nonetheless, the same binding geometry is observed in both cases and the clustering algorithm correctly assigns the molecules into the same cluster.

Overall, the primary functionality that facilitates interaction with His-163 is the nitrogen-containing heterocycle present in almost all fragments in cluster 5 (Figure 16) ; the exception is x0967, which forms the His-163 HB via its phenol oxygen. Such heterocycles are well suited to replace the substrate P1 Gln sidechain by mimicking its HB donor/acceptor abilities. In addition, most cluster 5 binders also reach into the hydrophobic S2 pocket, although no clear trend in functional group preference for S2 can be observed for cluster 5. This is in accord with our plasticity analysis, which shows that the S2 subsite residues are plastic and can accommodate a large variety of inhibitors. As seen in the overlap of peptide inhibitor p13 and cluster 5 representative x0678 (Figure 15e) , the binding mode of both inhibitors in the S1 and S2 subsites are very similar, with both compounds forming HBs to His-163 and Glu-166 and binding deep in the S2 pocket.

The interactions between the fragments and M pro were also analysed by employing linear scaling DFT, as for the substrates and designed peptides. Using short-range (Econt) DFT interactions with M pro as a "descriptor" for clustering, a cluster containing both the substrates and the cluster 5 compounds (x0107, x0434, x0540, x0678, x0967 and x1093) was identified (Figure S4.6) . This cluster also includes compounds x0426, x0946, x0195, x0995, x0104, x0874, x1077, x0161 and x0397. This analysis reveals fragments with similar interaction patterns to those exhibited by substrates. Unlike the Arpeggio-based analysis, BigDFT clustering can group fragments together that exhibit long-range interaction patterns that are similar to the natural substrates (highlighted in purple in Figure S4 .6), identifying compounds that could potentially lead to tighter binding. This agnostic analysis provides a new and potentially powerful way to evaluate compounds of differing sizes and nature based on quantum mechanical descriptors obtained from biomolecular complexes. Cluster 5 binders are therefore promising building blocks for substrate-competing inhibitor design. On the other hand, cluster 1 binders make up the bulk of covalent compounds in the fragment dataset and should therefore be considered when designing covalent inhibitors.

As of the 11th of January 2021, the COVID Moonshot M pro inhibitor project had reported fluorescence assay data for 798 inhibitors and rapid fire assay data for 784 inhibitors, 18,33 245 of which had X-ray crystal structures in complex with M pro . To test our hypothesis that the interactions identified in the substrate and fragment analyses are important for inhibitor design, the Moonshot structures were processed with Arpeggio and ligand-M pro interaction fingerprints were generated and compared to the most important interactions identified in fragment cluster 5. A Moonshot compound was classified as a cluster 5 binder if it shared at least 70% of the atom contacts found in cluster 5 binders. This analysis resulted in 101 assayed cluster 5 binders (Figure 17) . Since the sensitivity of the activity assays are capped at 99 μM, weak binders could not be accurately quantified and were labelled with IC50 values of 99 μM. 33 In the following analysis the fluorescence assay data (N=798 inhibitors) was used.

When comparing the average IC50 of cluster 5 binders with the rest of the dataset, cluster 5 binders bind slightly more tightly with an average IC50 of 42.2 μM (95% confidence interval: 34.55-49.87 μM), while the average IC50 of all compounds is 54.0 μM (95% confidence interval: 50.95-57.07 μM). However, given the bimodal distribution of the data (see Figure S4 .7), a better metric is the hit rate of good compounds and the number of 'inactive' compounds in the dataset: 2 of the 10 best Moonshot compounds are cluster 5 binders, as are 10 of the top 10% (81 compounds) of Moonshot compounds. Out of the 101 cluster 5 binders, only 15 were identified as weak binders, while out of all 798 assayed compounds 263 (33%) were weak or nonbinders. As a result, this observed IC50 difference between cluster 5 binders and other inhibitors might be higher than currently calculated. Note, only 245 of the 798 assayed compounds had been structurally solved so it is unknown how many of the unsolved compounds are also cluster 5 binders.

Thus, by analysing fragment and substrate interactions with M pro , we were able to extract and cluster structural interaction fingerprints and found in cluster 5 a promising non-covalent binding mode in the M pro active site. Analysis of the large set of assayed Moonshot compounds reveals that cluster 5 binders are more potent inhibitors with a higher hit rate of stronger actives than the rest of the dataset. Cluster 5 binders represent highly promising starting points for further optimisation.

We selected the 540 covalently reacting compounds of the 10,001 designed Moonshot compounds and docked them using the knowledge-based pre-alignment docking method using AutoDock4 (Section S1.10). 69 These compounds were designed by the Moonshot consortium, usually using one or more of the 44 covalent fragments as a core structure. 33 Only compounds with a matching covalent warhead to the inspiration fragment that also cite a single covalent fragment as their inspiration were selected to form the dataset of 540 compounds. To take advantage of the many diverse induced-fit conformations of M pro , each designed compound was docked into the M pro structure of the corresponding covalent "inspiration fragment". 33 The lowest energy docked pose in the highest populated cluster of each docking run was used to identify contacts using Arpeggio and generate the interaction Tanimoto distance matrix using a Tanimoto similarity threshold of 0.5 or 0.7 between poses of each cluster as described above for the XChem fragments. The broader clustering threshold of 0.5 leads to a total of 5 clusters, with the first cluster containing 477 of the 540 poses (88%) and no single-pose clusters; while the tighter threshold of 0.7 results in 46 clusters with 12 single molecule clusters. As expected, the diversity of binding modes of these compounds is much lower than in the original XChem fragment set, due to the limited number of fragments (44) and the reduced structural diversity of the designs, all being covalent S1/S1ʹ binders.

We subsequently analysed the ability of the procedure to recapitulate the binding pose of the parent fragment when docking the fragment-based Moonshot designs. We compared the shape and pharmacophoric (SuCOS) overlap of the lowest energy pose of the highest populated cluster for each Moonshot compound with the inspiration covalent XChem fragment referenced by the designers (Figure S4.8) . A SuCOS score of 0.5 and higher was sufficient to consider the binding poses of the crystallographic fragment and docked design as conserved. 70 Due to creative freedom in the design process, some of the designed compounds do not overlap significantly with the inspiration fragments and only have the covalent warhead in common in some extreme cases. When controlling for the smallest maximum common substructure (MCS) that encompasses at least the covalent warhead and one additional atom in the compound, 379 docked designs remain, from which 132 (34.8%) recovered the binding mode of the inspiration fragment. Given the high similarity between the fragments and the docked designed compounds, it is likely that these binding modes are more representative of the actual binding mode of the ligand.

At the point of analysis, only 6 of the 540 docked covalent compounds have been analysed crystallographically. 54 These structures were used as a limited benchmark for the docking method; an overlay of the crystallographic conformation, the lowest energy pose of the highest populated cluster from docking, and the corresponding crystallographic structure of the inspiration fragment is shown in the SI (Figure S4.9 ). x10899 (Figure S4 .10) was excluded from further analysis since it binds via a crystal contact to a third symmetry-related M pro molecule, rather than the biologically relevant dimeric state. 4 The binding modes of two compounds, x3077 and x10306 (Figure S4.9a and S4 .9e respectively), were reproduced perfectly. The method places the aromatic sidechain of x3324 (Figure S4 .9b) correctly into the S2 pocket of M pro but varies on placement of the linker when compared to the crystal structure. However, in this case, the original fragment that was cited as inspiration has no overlap with the designed compound. As a result, the induced fit shape of the active site of the M pro structure used for docking complements a completely different molecule and the alignment before docking pointless. For x3325 and x10172 ( Figure  S4.9c and S4.9d respectively) , the selected lowest-energy pose of the highest populated cluster did not match the binding pose of the crystal structure.

In summary, the docking method identifies the correct binding mode when good overlap exists between the inspiration fragment and designed compound beyond the covalent warhead., However, it struggles to dock larger, more extended molecules or compounds where small changes substantially affect binding. For example, for designed compound x3325 and the fragment used as its inspiration, x1386, the change from the thiophene group to the acetylene group in x3325 leads to a major change in binding mode when comparing their crystal structures (Figure S4.9) . Perhaps a more-human guided approach to docking (using iMD-VR) could be useful for these larger molecules, where chemical and spatial intuition can influence the resulting docked structure. As more structures become available, it will be possible to further validate the use of parent-fragment induced-fit structures in docking. The performance of our docking method appears to be in line with the active-guided docking hypothesis, where an induced fit structure and pre-alignment of fragment-derived compounds to known fragment crystal structures is only valid if the compound does not differ drastically from the parent fragment. All poses of the 540 docking runs and their SuCOS scores are available in the SI Files.

With a view to designing novel inhibitors, we compared the interactions of the cluster 5 binders observed in the crystal structures of the Moonshot designs, and those observed with the substrate peptides and the XChem fragments. Interestingly, unlike substrates, almost none of the cluster 5 binders interact with the oxyanion hole. The only cluster 5 compounds where this contact is made are a series of covalent inhibitors, none of which showed promising potency (Figure S4.11 ). An exhaustive search of Moonshot structures showed that no non-covalent inhibitor has ever been tested that includes both the typical cluster 5 binding mode while also being able to interact with the oxyanion hole.

We then compared the structures of the top 10 compounds in cluster 5 (part of the dataset analysed in Section 4.2) to the docked structures of covalent Moonshot designs (Section 4.3) . Two docked compounds (FOC-CAS-e3a94da8-1 and MIH-UNI-e573136b-3) were selected based on the high SuCOS overlap with their inspiration fragments, strongly suggesting that the docked binding mode reflects the actual pose of the ligand. Both docked compounds bind into the oxyanion hole as well as into S1 and S2, providing a clear opportunity for extension of the cluster 5 binders (Figure S4.12) .

Most cluster 5 binders connect the aromatic heterocycle binding into the S1 site with the carbonyl hydrogen bonding to Glu-166 through an amide linker. The position of this amide nitrogen overlays perfectly with the ring amine present in the docked compound FOC-CAS-e3a94da8-1 (Figure 18a) . As a result, extension of cluster 5 binders into the oxyanion hole might best be performed through the addition of a substituent at the amide nitrogen, circumventing the issue of stereochemistry present in the covalent designs FOC-CAS-e3a94da8-1 and MIH-UNI-e573136b-3, where the connection of the pyridine to the core six-membered ring creates a stereocenter on the core ring. The most promising basis for the extension is perhaps x10789, which makes a HB with the backbone oxygen of Glu-166 (Figure 18a ). When comparing interactions exhibited by cluster 5 binders (Glu-166, His-163) or covalent fragments (Gly-143, Cys-145) with the contacts present in the docked structure of the recently published Phase 1 clinical trial candidate PF-07321332 by Pfizer (Figure  18b) , 11,12 we see an almost identical interaction pattern to the cluster 5 binding motif. However, it is notable that for reacted PF-07321332, AutoDock4 was unable to place the negatively charged azanide in the oxyanion hole, which would be its expected position given its similarity to related warheads previously described and docked (see SI), where a carbonyl oxygen is almost always docked correctly in the oxyanion hole.

A wealth of crystal structures of SARS-CoV-2 M pro is available, including hundreds with ligands. There is thus the question of how best to use this static information to help develop M pro inhibitors optimised in terms of efficacy and safety for COVID-19 treatment.

The dimeric nature of M pro , coupled with its multiple substrates, makes it challenging to understand the structural and dynamic features underpinning selectivity and catalysis, as is the case for many other proteases. Such an understanding is, of course, not essential to develop medicines, as shown by work with other viral proteases. Still, it may help improve the quality of such medicines and the efficiency with which they are developed. It will also lay the foundation for tackling anti-COVID-19 drug resistance -a challenge we will likely encounter as experience with the HIV global pandemic implies. The scale of global efforts on M pro makes this system an excellent model for collaborative efforts linking experimental biophysics, modelling, and drug development (Figure 19 ).

The results of our combined computational studies, employing classical molecular mechanics and quantum mechanical techniques, ranging from automated docking and MD simulations to linearscaling DFT, QM/MM, and iMD-VR, provide consistent insights into key binding and mechanistic questions. One such question concerns the protonation state of the 'catalytic' His-41/Cys-145 dyad, an important consideration in the rate of reaction of covalently linked M pro inhibitors which ultimately relates to their selectivity and potency. Our results indicate that a neutral catalytic dyad is thermodynamically preferred in M pro complexed with an unreacted substrate, justifying the neutral state for MD simulations. A more reactive thiolate anion may be deleterious to the virus, as it will be susceptible to reaction with electrophiles. Importantly, analysis of the active site suggests that the precise mechanism of proton transfer in the His-41/Cys-145 dyad involves dynamic interactions with other residues, including His-163, His-164, Asp-187, and a water hydrogen bonded to the latter two residues and His-41. Proton transfer may be considered a relatively simple part of the overall catalytic cycle -these results thus highlight how M pro catalysis is likely a property of (at least) the entire active site region, with a future challenge being to understand motions during substrate binding, covalent reaction, and product release.

The models we have developed of M pro in complex with its 11 natural substrates provided a basis for analysis of key interactions involved in substrate recognition and for comparison with (potential) inhibitor binding modes. Notably, the Pʹ (C-terminal) side of substrates appears to be much less tightly bound than the P (N-terminal) side, where there is remarkable consistency in the hydrogen bonding patterns across the substrates. This difference may in part reflect the need for the Pʹ side to leave (at least from the immediate active site region) after acyl-enzyme complex formation and prior to acylenzyme hydrolysis. The tighter binding of the N-terminal P-side residues suggests these are likely more important in substrate recognition by M pro . This is also reflected in potent inhibitors, such as N3 and peptidomimetic ketoamides, 2,4 which predominantly bind in the non-prime S subsites. The development of S-site-binding inhibitors may also reflect the nature of the substrates used in screens leading to them, which typically comprise an S-site binding peptide with a C-terminal group enabling fluorescence-based measurement. Our results imply that there is considerable scope for developing inhibitors exploiting the Sʹ subsites, or both S and Sʹ subsites, though relatively more effort may be required to obtain tight binders compared to targeting the S subsites. Consistent with prior studies, our work highlights the critical role of the completely conserved P1 Gln residue in productive substrate binding and analogously in inhibitor binding. However, the nature of the P2/S2 interaction is also important in catalysis. In the natural substrates (Figure 1) , the P2 position is Leu in 9 of the 11 substrates, Phe in s02 (which displays medium turnover efficiency), and Val in s03 (which is a poor substrate). Our results show that the S2 subsite plays a critical role in recognition and inhibition. This site is highly plastic (Figure 7 ) and can accommodate a range of different ligands, including larger groups, though not necessarily in a productive manner. The observation that substrates with a P2 Leu vary in efficiency reveals that interactions beyond those involving P1 and P2 are important, reinforcing the notion that (likely dynamic) interactions beyond the immediate active site are important in determining selectivity both in terms of binding and rates of reaction of enzyme-substrate complexes. Notably, the results of computational alanine scanning mutagenesis, aimed at identifying peptides that would bind more tightly than the natural substrates, led to the finding that substitution of a Trp at P2 ablates hydrolysis creating a substrate-competing inhibitor. There is thus scope for the development of tight binding peptidic M pro inhibitors, for use in inhibition and mechanistic/biophysical studies.

Finally, the combined analysis of interactions involved in substrate binding and extensive structural information on inhibitor/fragment binding to M pro enabled us to identify a cluster of inhibitors whose interactions relate to those conserved in substrate binding (e.g., involving the Glu-166 backbone, His-163 sidechain, and/or the oxyanion hole formed by the Cys-145 and Gly-143 backbones). Building out from these 'privileged' interactions (Figure 18 ) might be a useful path for inhibitor discovery. Indeed, an M pro inhibitor now in clinical trials 11,12 exploits the same 'privileged' interactions that we identified. We hope the methods and results that have emerged from our collaborative efforts will help accelerate the development of drugs for treatment of viral infections, and particularly COVID-19.

A detailed description of the experimental and computational methods employed in this work is provided in the supporting information. Further information has also been made publicly available in GitHub (https://github.com/gmm/SARS-CoV-2-Modelling). 

There are no conflicts to declare.

C&EN: Pfizer unveils its oral SARS-CoV-2 inhibitor